<span style="color: #222222;">COVID-19 may increase the risk of blot clots in pregnant women, or in those taking estrogen with birth control or hormone replacement therapy, say scientists.<br />”<br />”According to the researchers, one of the many complications of COVID-19 is the formation of blood clots in otherwise healthy people.<br />”<br />”Researchers, &nbsp;including those from the Tufts University School of Medicine in the US, said the female hormone estrogen also increases the chance of blood clots during pregnancy, and in women taking birth control pills or hormone replacement therapy.<br />”<br />”The research, published in the journal Endocrinology said, if infected with COVID-19, the risk of blood clotting could be even higher, and these women may need to undergo anticoagulation therapy, or discontinue their estrogen medicines.<br />”<br />”Daniel Spratt, the study's corresponding author from Tufts University School of Medicine in Boston, US said additional research is needed to determine if women who become infected with the coronavirus during pregnancy should receive anticoagulation therapy, or if women taking birth control pills or hormone replacement therapy should discontinue them.<br />”<br />”According to the researchers, collaborative efforts between clinicians and basic researchers, and between endocrinologists and hematologists are necessary to understand the interactions between the novel coronavirus and pregnancy or estrogen therapy that could guide clinical management.</span><br />